Aidigong Maternal & Child Health (SEHK:286) - Aandelenkoers, Nieuws & Analyse

286 Overzicht aandelen

Aidigong Maternal & Child Health Limited, een investeringsholding, biedt postpartumzorg en gezondheidszorg in de Volksrepubliek China.

Over het bedrijf

286 fundamentele analyse
Sneeuwvlok Score
Waardering	4/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	3/6
Dividenden	0/6

Beloningen

Verhandeld tegen 41.6% onder onze schatting van de reële waarde

Risicoanalyse

De winst is de afgelopen 5 jaar met 17.5% per jaar gedaald

Aandeelhouders zijn het afgelopen jaar verwaterd

Heeft geen betekenisvolle marktkapitalisatie ( HK$297M )

Volatiele aandelenkoers in de afgelopen 3 maanden

Aidigong Maternal & Child Health Limited Concurrenten

Human Health Holdings

SEHK:1419

HK$307.4m

Bamboos Health Care Holdings

SEHK:2293

HK$261.6m

Clarity Medical Group Holding

SEHK:1406

HK$203.6m

Meihao Medical Group

SEHK:1947

HK$225.1m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Aidigong Maternal & Child Health
Historische aandelenkoersen
Huidige aandelenkoers	HK$2.01
52 Week Hoogtepunt	HK$14.40
52 Week Laag	HK$1.25
Bèta	0.43
11 maand verandering	-43.70%
3 maanden verandering	1.01%
1 Jaar Verandering	-79.90%
33 jaar verandering	-94.29%
5 jaar verandering	-91.34%
Verandering sinds IPO	-100.00%

Recent nieuws en updates

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Sep 25

Recent updates

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Sep 25

Investors Don't See Light At End Of Aidigong Maternal & Child Health Limited's (HKG:286) Tunnel And Push Stock Down 26%

Jun 06

Take Care Before Jumping Onto Aidigong Maternal & Child Health Limited (HKG:286) Even Though It's 28% Cheaper

Mar 22

A Look At The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Jul 06

Aidigong Maternal & Child Health Limited (HKG:286) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Jun 14

Calculating The Intrinsic Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Mar 27

Is Aidigong Maternal & Child Health Limited (HKG:286) Trading At A 24% Discount?

Dec 21

Is Aidigong Maternal & Child Health (HKG:286) Using Debt In A Risky Way?

Oct 13

Estimating The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Sep 02

Aidigong Maternal & Child Health (HKG:286) Has A Somewhat Strained Balance Sheet

Jun 29

Aidigong Maternal & Child Health (HKG:286) Use Of Debt Could Be Considered Risky

Aug 31

Do Institutions Own Aidigong Maternal & Child Health Limited (HKG:286) Shares?

Feb 21

Is Aidigong Maternal & Child Health Limited's (HKG:286) Stock Price Struggling As A Result Of Its Mixed Financials?

Jan 17

Aidigong Maternal & Child Health's(HKG:286) Share Price Is Down 14% Over The Past Three Years.

Dec 12

Rendement voor aandeelhouders

	286	HK Healthcare	HK Markt
7D	-9.9%	4.2%	3.9%
1Y	-79.9%	-18.6%	19.4%

Rendement versus industrie: 286 presteerde slechter dan de Hong Kong Healthcare -sector, die het afgelopen jaar een rendement van -18.6 % opleverde.

Rendement versus markt: 286 presteerde slechter dan Hong Kong Market, dat het afgelopen jaar een rendement van 19.4 % opleverde.

Prijsvolatiliteit

Is 286's price volatile compared to industry and market?
286 volatility
286 Average Weekly Movement	17.5%
Healthcare Industry Average Movement	8.4%
Market Average Movement	8.9%
10% most volatile stocks in HK Market	18.9%
10% least volatile stocks in HK Market	4.2%

Stabiele aandelenkoers: De aandelenkoers van 286 is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 17% ) van 286 is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen Hong Kong.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1990	1,338	Aier Wang	www.aidigong.hk

Aidigong Maternal & Child Health Limited, een investeringsholding, biedt postpartumzorg en gezondheidsdiensten aan in de Volksrepubliek China. Het bedrijf is actief via de segmenten Postpartumzorg, Gezondheidszorg en Overige. Het biedt diensten aan op het gebied van gezondheidszorg voor moeder en kind, medische antiverouderingsdiensten, investeringsdiensten voor de gezondheidszorgindustrie en diensten op het gebied van de ontwikkeling van gezondheidszorgvastgoed, evenals diensten op het gebied van management, investeringen en financiën.

Aidigong Maternal & Child Health Limited Samenvatting

Hoe verhouden de winst en inkomsten van Aidigong Maternal & Child Health zich tot de beurswaarde?
286 fundamentele statistieken
Marktkapitalisatie	HK$297.15m
Inkomsten(TTM)	-HK$192.96m
Inkomsten(TTM)	HK$522.09m

0.6x

P/S-verhouding

-1.5x

Koers/Winstverhouding

Is 286 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
286 resultatenrekening (TTM)
Inkomsten	HK$522.09m
Kosten van inkomsten	HK$424.06m
Brutowinst	HK$98.03m
Overige uitgaven	HK$290.99m
Inkomsten	-HK$192.96m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-1.31
Brutomarge	18.78%
Nettowinstmarge	-36.96%
Schuld/Eigen Vermogen Verhouding	78.3%

Hoe presteerde 286 op de lange termijn?

Bekijk historische prestaties en vergelijking

286 Overzicht aandelen

Beloningen

Risicoanalyse

Aidigong Maternal & Child Health Limited Concurrenten

SEHK:1419

HK$307.4m

SEHK:2293

HK$261.6m

SEHK:1406

HK$203.6m

SEHK:1947

HK$225.1m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Now 33% undervalued

Now 26% undervalued

First half 2024 earnings released: HK$0.33 loss per share (vs HK$0.22 loss in 1H 2023)

New minor risk - Share price stability

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Aidigong Maternal & Child Health Limited(SEHK:286) dropped from S&P Global BMI Index

Recent updates

Now 33% undervalued

Now 26% undervalued

First half 2024 earnings released: HK$0.33 loss per share (vs HK$0.22 loss in 1H 2023)

New minor risk - Share price stability

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Aidigong Maternal & Child Health Limited(SEHK:286) dropped from S&P Global BMI Index

First half 2024 earnings released: HK$0.33 loss per share (vs HK$0.22 loss in 1H 2023)

Aidigong Maternal & Child Health Limited to Report First Half, 2024 Results on Aug 30, 2024

Aidigong Maternal & Child Health Limited, Annual General Meeting, Jun 28, 2024

Investors Don't See Light At End Of Aidigong Maternal & Child Health Limited's (HKG:286) Tunnel And Push Stock Down 26%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Take Care Before Jumping Onto Aidigong Maternal & Child Health Limited (HKG:286) Even Though It's 28% Cheaper

Aidigong Maternal & Child Health Limited has filed a Follow-on Equity Offering in the amount of HKD 62.09021 million.

Aidigong Maternal & Child Health Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

New minor risk - Insider selling

Chairman & CEO recently sold HK$8.4m worth of stock

New major risk - Share price stability

Chairman & CEO recently bought HK$1.4m worth of stock

New minor risk - Shareholder dilution

Chairman of the Board & CEO recently bought HK$247k worth of stock

Aidigong Maternal & Child Health Limited Announces Board and Committee Changes

Aidigong Maternal & Child Health Limited Announces Resignation of Guo Qifei Has as Non-Executive Director

First half 2023 earnings released: HK$0.005 loss per share (vs HK$0.014 loss in 1H 2022)

First half 2023 earnings released: HK$0.005 loss per share (vs HK$0.014 loss in 1H 2022)

Aidigong Maternal & Child Health Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023

Aidigong Maternal & Child Health Limited to Report First Half, 2023 Results on Aug 31, 2023

Executive Director recently bought HK$6.3m worth of stock

A Look At The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Aidigong Maternal & Child Health Limited (HKG:286) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Full year 2022 earnings: EPS and revenues miss analyst expectations

Calculating The Intrinsic Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Now 22% undervalued after recent price drop

Aidigong Maternal & Child Health Limited Announces Director Appointments

Is Aidigong Maternal & Child Health Limited (HKG:286) Trading At A 24% Discount?

Aidigong Maternal & Child Health Limited announced that it expects to receive HKD 224.719102 million in funding from Zhuhai Deyou Bohui Enterprise Management Consulting (Limited Partnership)

Now 24% undervalued after recent price drop

Aidigong Maternal & Child Health Limited Announces Executive Changes

Price target decreased to HK$0.60

Less than half of directors are independent

Is Aidigong Maternal & Child Health (HKG:286) Using Debt In A Risky Way?

First half 2022 earnings released: HK$0.014 loss per share (vs HK$0.006 profit in 1H 2021)

Now 25% undervalued

Estimating The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

First half 2022 earnings released: HK$0.014 loss per share (vs HK$0.006 profit in 1H 2021)

Aidigong Maternal & Child Health Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

Aidigong Maternal & Child Health Limited Announces Resignation of Wong Kin Man as a Non-Executive Director

Aidigong Maternal & Child Health (HKG:286) Has A Somewhat Strained Balance Sheet

Aidigong Maternal & Child Health Limited, Annual General Meeting, Jun 28, 2022

Aidigong Maternal & Child Health Limited Announces Resignation of Yang Zhibo as Non-Executive Director

Price target decreased to HK$0.65

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Chairman of the Board & CEO recently bought HK$1.2m worth of stock

First half 2021 earnings released: EPS HK$0.006 (vs HK$0.007 in 1H 2020)

Independent Non Executive Director Yang Guang Mai has left the company

Aidigong Maternal & Child Health (HKG:286) Use Of Debt Could Be Considered Risky

First half 2021 earnings released: EPS HK$0.006 (vs HK$0.007 in 1H 2020)

Aidigong Maternal & Child Health Limited has completed a Follow-on Equity Offering in the amount of HKD 117.8 million.

An unknown buyer entered into an agreement to acquire 49% stake Shenzhen Wanqi Marine Bio Tech Company Limited from Aidigong Maternal & Child Health Limited (SEHK:286) for HKD 25 million.